Trials / Completed
CompletedNCT00165620
A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
To establish the optimum injection rate for E7337 (Iomeron 350) in dynamic CT in patients who have hepatic lesions.The primary endpoint for efficacy is the contrast enhancement effect in the early arterial phase, and the primary safety endpoints are warming sensation and vascular pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iomeprole |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2005-04-01
- First posted
- 2005-09-14
- Last updated
- 2010-01-29
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00165620. Inclusion in this directory is not an endorsement.